Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.


Insights into the Resolution of Inflammation

Insights into the Resolution of Inflammation
Reported by
Sara Donnelly

Posted February 25, 2020

Presented By

The New York Academy of Sciences


Inflammation is a common feature of many widely occurring human diseases. In recent years, our understanding of the molecular mechanisms regulating inflammation has improved dramatically, most notably with the identification of active processes that control the resolution of the inflammatory response. Now, this rapidly evolving field of research – Resolution Pharmacology — promises novel approaches for the treatment of myriad inflammatory diseases. In this webinar, the first in a four-part series, leaders in the field explore recent research on the molecular mechanisms driving the resolution of inflammation and approaches to therapeutically target these pathways in chronic inflammatory and autoimmune diseases.

In This Webinar, You’ll Learn

  • The key steps required for the successful resolution of inflammation.
  • How pro-resolving mediators, including lipoxins, resolvins, maresins, and protectins are biosynthesized and how they regulate resolution.
  • How defects in resolution pathways contribute to chronic autoimmune and inflammatory conditions.
  • Emerging strategies to therapeutically target the resolution of inflammation in diabetes and its associated complications including atherosclerosis, kidney disease, and fibrosis.
Insights into Inflammation Resolution